Lamivudine-refractory, chronic hepatitis B patients can be safely switched to entecavir 1.0 mg daily without risk of ALT flare


Boyer T., Sherman M., Yurdaydin C., Sollano J., Silva M., Chen L., ...More

6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Washington, Kiribati, 25 - 28 October 2004, vol.9, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 9
  • City: Washington
  • Country: Kiribati
  • Ankara University Affiliated: No